Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Kochetkova, L. Ugay, V. Nevzorova, G. Massard, Y. Maistrovskaia (Vladivostok, Russian Federation; Strasbourg, France). Adipokines in end-stage lung diseases: The crosstalk between bone and adipose tissue. Eur Respir J 2013; 42: Suppl. 57, 408

Member's Comments

No comment yet.

Related content which might interest you: Role of serum and tissue vascular remodeling markers in bone loss related to end-stage COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Osteoporosis and adipose tissue expression of adipokines and osteoprotegerin in severe chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 Low lung volume is associated with visceral adipose tissue inflammation Source: Annual Congress 2013 –Clinical physiology and functional imaging in health and disease Year: 2013 Serum B cell activating factor (BAFF) as a prognostic biomarker in interstitial lung diseases associated with connective tissue diseases Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Serum surfactant protein D is a potential biomarker of lung damage in systemic sclerosis Source: International Congress 2016 – Connective tissue disorders Year: 2016 Chemical exposure triggering connective tissue disease with lung involvement Source: International Congress 2015 – Occupational disease: clinical cases and series Year: 2015 Interleukin-6 in systemic sclerosis and potential correlation with pulmonary involvement Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Adipokines and ghrelin in chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD treatment and others Year: 2013 HCMV infection triggers the development of interstitial lung diseases in autoimmune disorders Source: International Congress 2014 – IPF and surroundings Year: 2014 Lung structure and function relation in systemic sclerosis: Application of lung densitometry Source: International Congress 2015 – A more functional view of chest pathology Year: 2015 Evaluation and treatment of interstitial lung involvement in connective tissue diseases: a clinical update Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=27 Year: 2005 Lung transplantation for systemic sclerosis and other connective tissue diseases Source: International Congress 2017 – Difficult indications for lung transplantation Year: 2017 Pulmonary involvement in Moldova lupus study Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013 Risk factors for pulmonary hypertension and associations with lung function in connective tissue diseases Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010 The value of biomarkers in the rheumatoid arthritis related interstitial pneumonia Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Serum KL-6 as a biomarker to assess response to azathioprine in connective tissue disease associated lung disease (CTD-ILD) Source: International Congress 2015 – Connective tissue disorders Year: 2015 Inflammatory mediators associated with bone metabolism in patients awaiting lung transplantation Source: Annual Congress 2012 - Clinical management of lung diseases: from bronchi to pleura Year: 2012 Possible role of liver disease and respiratory insufficiency in osteopenia in cystic fibrosis patients Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 Uncoupling the pro-fibrotic effects of TGF-beta1 versus tissue hardening in lung fibroblasts Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013